ThinkSabio

$VCYT

$50.20▲ +0.4% YTD

8 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History
News
VCYT ▲ +0.4% - Veracyte, Inc.
CP $50.20▲ +0.4%Nov 2, 2026 · ThinkSabio Blog

$VCYT - Ten Afirma Abstracts to Highlight Thyroid Nodule Diagnosis and Cancer Research at ATA 2026…

News
VCYT ▲ +3.6% - Veracyte, Inc.
CP $52.17▲ +3.6%Oct 29, 2026 · ThinkSabio Blog

$VCYT - Veracyte to Participate in Upcoming Investor Conferences…

News
VCYT ▲ +1.0% - Veracyte, Inc.
CP $43.56▲ +1.0%Oct 19, 2026 · ThinkSabio Blog

$VCYT - Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026…

News
VCYT ▲ +2.5% - Veracyte, Inc.
CP $45.48▲ +2.5%Oct 16, 2026 · ThinkSabio Blog

$VCYT - Veracyte Secures Medicare Reimbursement for Prosigna Breast Risk of Recurrence Test…

News
VCYT ▲ +0.9% - Veracyte, Inc.
CP $43.51▲ +0.9%Oct 14, 2026 · ThinkSabio Blog

$VCYT - Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026…

News
VCYT ▲ +0.8% - Veracyte, Inc.
CP $45.60▲ +0.8%Sep 29, 2026 · ThinkSabio Blog

$VCYT - Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation…

News
VCYT ▼ -6.5% - Veracyte, Inc.
CP $45.43▲ -6.5%Sep 25, 2026 · ThinkSabio Blog

$VCYT - Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026…

News
VCYT ▲ +0.7% - Veracyte, Inc.
CP $43.43▲ +0.7%Sep 1, 2026 · ThinkSabio Blog

$VCYT - Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference…